Gault Laura 4
4 · Sage Therapeutics, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Award
Common Stock
2025-01-16+24,000→ 35,334 total
Footnotes (2)
- [F1]Consists of shares of common stock issuable under 24,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.
- [F2]Reflects beneficial ownership balance which includes 597 shares purchased on December 31, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.